DOH Logo linking to the DOH Home Page

Public Health Preparedness and Response for Bioterrorism:  2003 CDC Work Plans

Focus Area B: Surveillance and Epidemiology Capacity

Blue Line Image
You are here: DOH Home » CDC Application » CDC Grant Focus Area B Search | Employees
 Site Directory:    

Federal Applications Home

CDC Application Home

HRSA Application Home

Summary

Crosscutting Activities

Discussion of Local Involvement

 

Print versions (pdf files)

 


Access Washington Logo linking to Access Washington Home Page

 

Interim Progress Report - Budget Period Three

Critical Capacity: Rapidly detect a terrorist event through a highly functioning, mandatory reportable disease surveillance system

Critical Capacity: Rapidly and effectively investigate and respond to a potential terrorist event as evidenced by a comprehensive and exercised epidemiologic response plan

Critical Capacity: Effectively investigate and respond to naturally occurring individual cases of urgent public health importance, and conduct emergency public health interventions such as emergency chemoprophylaxis or immunization activities

Workplan - Budget Period Four

Critical Capacity 5: Disease detection through mandatory reportable disease surveillance system, as evidenced by ongoing timely and complete reporting

1. Develop a system to receive and evaluate urgent disease reports

2. Ensure legal authority to require and receive reports and investigate any suspect cases, potential terrorist events, unusual illness or injury

3. Annually assess your reportable disease surveillance system

4. Develop reporting protocols, procedures, surveillance activities, or analytic methods that improve usefulness of reportable disease system.

5. Provide ongoing training for public health, clinical, and other healthcare professionals

6. Ensure epidemiologic capacity to manage the reportable disease system at the state and local level

7. Educate and provide feedback to reporting sources in your jurisdiction about notifiable diseases

8. Assess and strengthen links with animal surveillance systems and the animal health community

9. Implement a strategy to ensure laboratory testing (in clinical or public health laboratories) for rapid or specific confirmation of urgent case reports

10. Improve state and local public health surveillance and reporting capacities related to smallpox

11. Develop or enhance electronic applications for reportable diseases surveillance

12. Develop the capacity to apply molecular epidemiologic methods  to outbreak investigations and surveillance

13. Establish relationship with state veterinary diagnostic laboratory

Critical Capacity 6: Effectively investigate and respond to a potential terrorist event as evidenced by a comprehensive and exercised epidemiologic response plan.

1. Designate an epidemiological response coordinator for bioterrorism

2. Coordinate all epidemiologic response-specific planning with HRSA hospital preparedness activities

3. Provide ongoing specialized epidemiology investigation and response training for state and local public health staff

4. Develop the capacity to track the degree to which persons who have not been exposed to a potential terrorist or emerging infectious agent seek acute care

5. Develop capacity of public health system to respond in a timely and appropriate manner to a food-, water-, or air-borne illness or threat

6.  Develop or acquire information sheets about bioterrorism for public use in a terrorist event

7.  Maintain a list of physicians and other providers who may serve as consultants during a public health emergency

8.  Develop and exercise a large-scale smallpox vaccination plan that will provide vaccine for the project’s entire population

9.  Establish a secure, Web-based reporting and notification system

10. Conduct bioterrorism sessions at key meetings and conferences

Critical Capacity 7: To effectively investigate and respond to naturally occurring individual cases of urgent public health importance and conduct emergency public health interventions such as emergency chemoprophylaxis or immunization activities

1.  Annually assess through exercises or after-action reports, the 24/7 capacity for response to reports of urgent cases

2.  Annually assess adequacy of state and local public health response to catastrophic infectious disease

3.  Develop or enhance case investigation protocols

4.  Provide necessary staffing, supplies, equipment, consultation, and training

5.  Participate in CDC’s Epidemic Information Exchange Program

6.  Educate key policy makers, partners and stakeholders regarding public health surveillance, investigation, response and control

7.  Apply information technology to enhance response capacity

8.  Develop a comprehensive smallpox response plan that incorporates post-event plans from participating hospitals

9.  Identify the number and type of personnel to serve as members on smallpox response teams who will be target recipients for vaccine

 Back to top

Budget Period Three Progress Report

Using the Interim Progress Report template below, provide a brief status report that describes progress made toward achievement of each of the critical capacities and critical benchmarks outlined in the continuation guidance issued by CDC in February 2002. Applicants should describe their agency’s overall success in achieving each critical capacity. The progress report narratives should not exceed 1 page, single-spaced, for each critical capacity. Applicants are welcome to use bullet-point format in their answers, so long as the information is clearly conveyed in the response.

CRITICAL CAPACITY: To rapidly detect a terrorist event through a highly functioning, mandatory reportable disease surveillance system, as evidenced by ongoing timely and complete reporting by providers and laboratories in a jurisdiction, especially of illnesses and conditions possibly resulting from bioterrorism, other infectious disease outbreaks, and other public health threats and emergencies.

Provide an update on progress during Project Year III toward achieving this critical capacity:

A statewide local health jurisdiction (LHJ) assessment, conducted in the fall of 2002, found that 20 of 35 LHJs have a dedicated telephone number for receiving disease reports after-hours and 25 of 35 local health jurisdictions use an on-call roster to ensure that public health staff can be contacted at any hour of the day.

The state and all nine public health regions hired epidemiologists or experienced disease investigation specialists as surveillance coordinators in order to improve surveillance for notifiable conditions across Washington State. Regional surveillance coordinators are resources for local health jurisdictions in their region. They facilitate region-wide communication, activities and training for public health surveillance.

Select cases of disease and disease outbreaks are required to be reported to local and state public health agencies in accordance with Washington Administrative Code (WAC) 246-101. The rules specify that suspected or confirmed diseases of potential bioterrorism origin and unexplained critical illness and death must be reported immediately. The Washington State Department of Health (DOH) Board of Health revised the quarantine authorities and these newly adapted administrative rules governing quarantine are part of WAC and took effect February 13, 2003.

DOH continues to develop the Public Health Issues Management System (PHIMS) with the goal of providing a secure, confidential mechanism for local health agencies to provide disease surveillance data through a Web-based system. DOH is coordinating this effort to assure that each LHJ can receive and evaluate disease reports of critical public health importance, 24 hours a day, either directly or through DOH via the Public Health Issues Management System (PHIMS).

DOH developed and distributed Washington State Guidelines for Notifiable Condition Reporting and Surveillance to all LHJs in order to provide public health staff with a single source for case definitions, reporting requirements, clinical information and control measures for each of our notifiable conditions. These guidelines were made available to health care providers, laboratories and other notifiable condition reporters on a new DOH Notifiable Conditions Web site (www.doh.wa.gov/notify).

Regions have provided regular training, including targeted outreach to healthcare providers on disease reporting and surveillance. The trainings improve awareness of methods and requirements for notifiable conditions reporting, particularly for immediately notifiable conditions. Training materials include LHJ and DOH phone numbers for reporting disease after hours. Surveillance coordinators have generated a list of key reporters in local health jurisdictions within each region for continued communication and education.

DOH developed the Vaccine Safety Surveillance (VSS) System to collect real-time, statewide data for all aspects of the smallpox vaccination program. The department developed a Web-based application and deployed it to all public health regions to provide a method for electronically reporting data, a, a to a single statewide database. The

database contains information on vaccinees, outcomes, clinics, clinic staff, referring organizations, and vaccine batches. DOH and its public health partners used standard VSS daily and weekly reports to plan and coordinate Stage 1 smallpox vaccination activities. DOH is currently evaluating the VSS and smallpox surveillance and will present reports documenting its findings at a statewide meeting in October. The agency continues to incorporate lessons learned from the development and evaluation of this system into the ongoing development of PHIMS.

Protocols for enhanced surveillance have been developed in some regions. They focus on monitoring key health indicators such as emergency department use and 911 calls. Three regions improved their capacity for early disease detection by developing or enhancing existing syndromic surveillance projects.

What is the status of your state’s development of a system to receive and evaluate urgent disease reports from all parts of your state and local public health jurisdictions on a 24-hour per day, 7-day per week basis? Choose only one of the following:

DOH response:
Development work is more than half way completed (51-75% completed)

Back to top

CRITICAL CAPACITY: To rapidly and effectively investigate and respond to a potential terrorist event as evidenced by a comprehensive and exercised epidemiologic response plan that addresses surge capacity, delivery of mass prophylaxis and immunizations, and pre-event development of specific epidemiologic investigation and response needs.

Provide an update on progress during Project Year III toward achieving this critical capacity:

DOH created nine public health regions to facilitate state, regional and local public health system collaboration around public health emergency preparedness activities. All nine regional lead LHJs have hired epidemiology response coordinators and submitted work plans to DOH that incorporate all LHJs in each region. The LHJs representing Metropolitan Statistical Areas (MSA) with a population greater than 500,000 each have at least one epidemiologist dedicated to bioterrorism and emergency response.

DOH completed an assessment of Public Health Preparedness and Response (PHEPR) in Washington State, which included an assessment of epidemiologic expertise in each LHJ. DOH analyzed this assessment data and presented results at a PHEPR Advisory Committee meeting and a PHEPR Focus Area Lead meeting. Results were summarized in a written report that was distributed to regional and state partners. Regional lead LHJs were provided data for all the LHJs in their region.

DOH surveyed its employees to identify skills in epidemiologic interviewing and investigation, second language proficiency, cultural experience and medical licensure. Those with appropriate skills were offered the opportunity to volunteer for the DOH smallpox response team. Additional staff that were not vaccinated but have appropriate skills will be targeted for training for surge capacity.

Work has begun on the development of regional Epidemiology Response Plans, which will be an annex to the Comprehensive Public Health Emergency Response Plans. A workgroup of regional and state epidemiology response coordinators has formed consensus on the main elements for the Epidemiology Response Plans and the group has begun writing sections of the plan and identifying Epidemiology Response Team members.

State and regional epidemiology response coordinators developed the Washington State Smallpox Response Plan. This plan addresses the capacity for enhanced epidemiologic and disease investigation across the state, including the identification and activation of local and state Rapid Assessment Teams, other surge capacity staff, case investigation, contact tracing, mass vaccination and monitoring for adverse effects.

DOH developed the Washington Prophylaxis and Vaccination Management System (PVMS) and used it during Stage 1 vaccinations in Washington. This database contains basic information on all public health and healthcare staff in Washington who received the smallpox vaccination, as well as a registry of smallpox vaccines.

The Smallpox Mass Vaccination Plan was also developed and exercised during the Stage 1 Smallpox vaccinations. DOH conducted train-the-trainer sessions during two pilot clinics held on the east and west sides of the state. State and regional staff were trained at these sessions. Subsequently, these staff trained staff in their regions to conduct Stage 1 smallpox vaccination clinics throughout the state. DOH conducted several interactive smallpox trainings around the state to improve adverse event recognition and reporting.

How many Metropolitan Statistical Areas (MSAs) with a population greater than 500,000 exist in your state?

Washington State has three MSAs with a population greater than 500,000: Seattle, Tacoma (Pierce County) and Snohomish County.

How many of these MSAs have at least one epidemiologist (1 FTE) dedicated to bioterrorist and emergency response?

The LHJs representing these MSAs each have at least one epidemiologist dedicated to bioterrorism and emergency response.

Back to top

CRITICAL CAPACITY: To rapidly and effectively investigate and respond to a potential terrorist event, as evidenced by ongoing effective state and local response to naturally occurring individual cases of urgent public health importance, outbreaks of disease, and emergency public health interventions such as emergency chemoprophylaxis or immunization activities.

Provide an update on progress during Project Year III toward achieving this critical capacity:

DOH’s Office of Communicable Disease Epidemiology maintains 24-hour reporting capacity through an on-call medical epidemiologist who can serve as a backup to LHJs that do not have their own system for 24-hour reporting. DOH collects twenty four-hour contact numbers for key DOH personnel, LHJ staff, and other state agencies that might respond to a public health emergency, updates the information biannually, and distributes it (the "Red Book") to other public health professionals. Many LHJs have specific phone numbers for after-hours reporting of notifiable conditions. Some LHJs have a general after-hours protocol for response to notifiable conditions, but many LHJs are still developing their protocols.

DOH manages list serves  [Information omitted in accordance with R.C.W. 42.17.310(1)(ww)]  to provide a forum for interactive communications with public health disease control specialists across the state. DOH Health Alerts, including Health Alerts Network (HAN) messages from the CDC, are currently disseminated through these list serves. DOH strives to ensure that multiple public health staff from each LHJ are members of the list serve. Additionally, LHJs are working to develop multiple and redundant means of communicating with their local partners such as list serves, monthly newsletters and broadcast fax.

Work has begun on the development of standardized protocols for public health investigation and response to outbreaks. A workgroup of state and regional epidemiology response coordinators convened in October 2002. This workgroup identified and reviewed existing protocols for disease outbreaks, case investigation and case management in order to identify best practices. The workgroup identified core elements to be included in all disease investigation protocols. The group developed a template and created protocols for select diseases as examples of protocols that could be standardized and used across the state. This group will continue to work on protocol development, starting with the immediately notifiable conditions.

Selected LHJs have been revising an outbreak evaluation tool that was presented at an annual statewide public health meeting. Some are using the evaluation tool for ongoing assessment of public health investigation and response.

The DOH Office of Communicable Disease Epidemiology hired a state public health veterinarian to add capacity for zoonotic disease surveillance and investigation. The State Public Health Veterinarian develops and provides education, communication mechanisms and protocols to improve animal disease surveillance. A response protocol for suspected human West Nile Virus infection was developed and shared across the state. A poster of animal notifiable conditions has been created and comments from regional response coordinators were solicited. The poster will be disseminated following inclusion of the comments and after training on handling of zoonotic reports from veterinarians is provided to public health staff.

Back to top

Budget Year Four Workplan

For each Recipient Activity applicants should complete the work plan templates attached below. Applicants are welcome to use bullet-point format in their answers, so long as the information is clearly conveyed in the response. All responses should be brief and concise. Please note that full use of the CDC templates will meet all of the requirements for submission of a progress report and work plan. Although no additional information is required, grantees may elect to submit other essential supporting documents via the web portal by uploading them as additional electronic files.

I. PUBLIC HEALTH SURVEILLANCE AND DETECTION CAPACITIES

CRITICAL CAPACITY #5: To rapidly detect a terrorist event through a highly functioning, mandatory reportable disease surveillance system, as evidenced by ongoing timely and complete reporting by providers and laboratories in a jurisdiction, especially of illnesses and conditions possibly resulting from bioterrorism, other infectious disease outbreaks, and other public health threats and emergencies. (See Appendix 4 for IT Functions #1-6.)

1. Complete development and maintain a system to receive and evaluate urgent disease reports and to communicate with and respond to the clinical or laboratory reporter regarding the report from all parts of your state and local public health jurisdictions on a 24-hour-per-day, 7-day-per-week basis. (CRITICAL BENCHMARK #7)

Strategies: What overarching approach(es) will be used to undertake this activity?

1. In conjunction with Focus Area A Critical Benchmark (CB) #3 and Focus Area E, achieve statewide consensus on the definition of 24-hour-per-day, 7-day-per-week public health response, which includes the receipt of urgent disease reports. Develop guidelines for after-hours evaluation, notification, and response. Incorporate the system for 24/7 receipt, evaluation, notification and response into State, Regional and Local Public Health Emergency Response Plans.

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. Define 24/7 coverage including basic parameters (i.e. maximum amount of time it should take for a reporter to reach health department staff, methods for recording and tracking all calls) for an effective system.

1b. Using the 24/7 definition and recommendations from other assessments (i.e., BioSense cities), develop a scalable model that will add efficiency and redundancy to public health agencies with existing systems for 24/7 response.

2a. Establish draft guidelines for after-hours evaluation, notification and response.

2b. Adapt guidelines appropriately on regional or local basis.

3a. Each LHJ will incorporate their 24/7 system for receipt, evaluation, notification and response into their Public Health Emergency Response Plans.

3b. State and local public health agencies will create or enhance 24/7 response using the developed model either internally or through agreements with other system partners

Timeline: What are the critical milestones and completion dates for each task?

1a. Definition developed by 9/12/03

1b. 24/7 system with scalable improvements written by 10/15/03

2a. Draft guidelines for after-hours evaluation, notification and response written by 11/30/03

2b. Guidelines modified for regional/local use by 12/30/03

3a. 24/7 evaluation and response system in place in all state & local public health agencies by 12/31/03

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1a. State and Regional Epidemiology Coordinators, Regional Emergency Response Coordinators (RERCs)

1b. State and Regional Epidemiology Coordinators

2a. Focus Area A/RERCs, State and Regional Epidemiology Coordinators

2b. Focus Area A/RERCs, Regional Epidemiology Coordinators; local communicable disease staff

3a. State and local Senior Health Officials

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

  • Percentage of LHJs that have identified a duty officer and established 24/7 coverage
  • Guidelines written for disease-specific after-hours evaluation, notification and response
  • Assessment of response (see Critical Benchmark #10)

Back to top

2. Ensure legal authority to require and receive reports and investigate any suspect cases, potential terrorist events, unusual illness or injury (e.g., chemical or radiological) clusters, and respond in ways to protect the public (e.g., quarantine laws).

Strategies: What overarching approach(es) will be used to undertake this activity?

1. Under Washington Administrative Code (WAC) 246-101, local and state health officers have the legal authority to require and receive reports and investigate diseases of public health importance, including immediate reporting of suspected or confirmed diseases of potential bioterrorism origin and unexplained critical illness and death. Local and state health officers can require reporting of additional conditions on a routine or emergency basis under the authority of the WAC. The newly adapted administrative rules (2/13/02) governing quarantine are part of WAC 246-100-040-070. DOH provides the following templates to local health officers and their legal counsel to facilitate adoption of quarantine and isolation orders on a local level:

  • Request for Voluntary Compliance
  • Emergency Involuntary Detention Order
  • Petition to Superior Court for an Ex Parte Order Authorizing Involuntary Detention
  • Petition for Order Authorizing Continued Detention

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. LHJs will review quarantine and isolation templates provided by DOH

1b. Using the templates provided by DOH or working with their own legal counsel, LHJs will carry out the necessary actions in order to adopt quarantine and isolation orders

1c. Based on the templates provided by DOH or LHJ legal council, develop legal authority section of Public Health Emergency Response Plans.

Timeline: What are the critical milestones and completion dates for each task?

1b. Adopt quarantine and isolation orders on a local level:
  • Local Request for Voluntary Compliance developed – varies by jurisdiction
  • Local Emergency Involuntary Detention Order developed - varies by jurisdiction
  • Local Petition to Superior Court for an Ex Parte Order Authorizing Involuntary Detention - varies by jurisdiction
  • Local Petition for Order Authorizing Continued Detention - varies by jurisdiction

1c Incorporate appropriate legal authorities into Regional and Local Public Health Emergency Response Plan - varies by jurisdiction

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1b. LHJ Senior Health Officials and their legal counsels

1c. RERCs, Regional Epidemiology Response Coordinators

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

Local Public Health Emergency Response Plans incorporate appropriate legal authorities.

Back to top

3. At least annually, with the input of local public health agencies, assess the timeliness and completeness of your reportable disease surveillance system for:

a. Outbreaks of illness and/or key categories of cases of reportable diseases, particularly those that are caused by agents of bioterrorism concern or those that mimic agents of bioterrorism concern; and others, such as influenza, invasive bacterial diseases, vaccine preventable diseases, vector-borne diseases, and food- and water-borne diseases.

b. Acute dermatological conditions/rash illnesses.

Strategies: What overarching approach(es) will be used to undertake this activity?

1. Annual assessments of the completeness and timeliness of notifiable disease surveillance will be conducted using a standardized statewide tool and through further evaluation, as appropriate.

2. The standardized evaluation will use existing and new surveillance system attributes (such as electronic disease reporting and new case report forms) and will focus on disease outbreaks and key notifiable diseases. Regional surveillance coordinators will select key notifiable conditions to assess for completeness and timeliness of reporting.

3. In addition to the standard evaluation, state, regional and/or local public health agencies will apply additional methods to further evaluate the performance of their surveillance system (i.e. case report review, active laboratory surveillance, hospital discharge data review).

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. Develop standard evaluation tool.

2a. Regional Surveillance Coordinators select key notifiable conditions to assess for timeliness annually

3a. Create a "toolbox" of further evaluation methods, including case report review, active laboratory surveillance, hospital discharge data review and other best practices that can be applied at the state, regional and/or local level as appropriate.

3b. Apply standard and other evaluation methods at the state, regional and/or local level.

Timeline: What are the critical milestones and completion dates for each task?

1a. Standard evaluation elements determined and questionnaire completed 1/2/04

2a. Disease outbreaks for review and key notifiable conditions selected - varies by jurisdiction

3a. Methods for further evaluation collected and described - varies by jurisdiction

3b. Assessment completed – varies by jurisdiction

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

All tasks - State and Regional Surveillance Coordinators

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

  • Standard evaluation questionnaire developed
  • Evaluation conducted at state and representative local public health agency in each region.

Back to top

4. Based on these assessments, develop or enhance reporting protocols, procedures, surveillance activities information dissemination, or analytic methods that improve the timeliness, completeness, and usefulness of the reportable disease system.

Strategies: What overarching approach(es) will be used to undertake this activity?

1. Statewide, results of the standardized evaluation (described above in CC #5 activity #3) will be summarized and recommendations for statewide, regional and/or local surveillance system improvements will be developed.

2. State and local public health agencies will produce a report summarizing their own deficiencies identified by the surveillance evaluation. This report will be accompanied by a documented plan of activities to improve notifiable conditions surveillance with implementation timelines.

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. Review data from standard evaluation questionnaire

1b. Develop recommendations for surveillance system improvement based on the findings from the evaluation

2a. Review standard and additional evaluation data at the agency level.

2b. Document deficiencies and develop plan for improvement.

Timeline: What are the critical milestones and completion dates for each task?

1. Report summarizing the findings of the standardized evaluation varies by jurisdiction

2. Recommendations for surveillance system improvement documented varies by jurisdiction

3a. Agency-level review documented varies by jurisdiction

3b. Plan for surveillance system improvement documented at each region varies by jurisdiction

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1a. State Surveillance Coordinator

1b. State and Regional Surveillance Coordinators

2a. State and Regional Surveillance Coordinators

2b. State and Regional Surveillance Coordinators

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

  • Regional plans incorporate surveillance system improvements

Back to top

5.a. Provide ongoing specialized disease surveillance and epidemiologic training for public health, clinical, and other healthcare professionals to develop subject matter expertise within the public health system for disease detection, contact tracing, and outbreak analysis. (LINK WITH FOCUS AREA G, CROSS CUTTING ACTIVITITY EDUCATION AND TRAINING, Attachment X)

b. Evaluate disease surveillance and epidemiologic training for public health personnel.

Strategies: What overarching approach(es) will be used to undertake this activity?

1. In coordination with Focus Area G, establish a system for identifying and developing public health and clinical subject matter experts, including identification of training/education appropriate for different types of subject matter experts. Work with Focus Area G Coordinator, Regional Learning Specialist (RLS), Focus Area B lead and Regional Epidemiology Coordinators to explore establishing a public health mentoring program, similar to the Florida EIS, for training in applied epidemiology and investigation, including specific criteria and performance objectives to be accomplished by participants.

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. Establish a state Epidemiology Learning Liaison to work closely with Focus Area G Coordinator, RLS and Regional Epidemiology Coordinators to identify, evaluate, develop curriculum and provide specialized surveillance and epidemiologic training for public health, clinical and other healthcare professionals.

1b. Link with Focus Area G and Washington Public Health Training Network (WAPHTN) to maintain a calendar of learning and training opportunities offered by public health, emergency response partners and academic institutions in the state relevant to epidemiology response activities.

1c. Catalogue, evaluate and communicate existing epidemiology and surveillance Web-based, video or other self-study training materials available through Public Health Training Network or other sources.

1d. Track and manage education and training through link with Focus Area G and the proposed Learning Management System.

1e. Identify and prioritize gaps in available epidemiology and surveillance training materials and develop strategies or partners (i.e., University of Washington’s Northwest Center for Public Health Practice) for filling those gaps.

1f. Develop standardized training specific to disease detection, contact tracing, outbreak analysis, PHIMS and other Web-based reporting and notification mechanisms.

1g. Provide training to local public health staff, partner agency staff, epidemiology response teams, health care providers, and others through statewide, regional or local meetings, train-the-trainer sessions, exercises and drills and evaluate training based on response.

1h. Establish, develop and maintain relationships with hospital education and training departments, infection control practitioners and continuing education coordinators to improve disease detection, contact tracing, and outbreak analysis; including participation in exercises for continuing education.

Timeline: What are the critical milestones and completion dates for each task?

1a. Hire state Epidemiology Learning Liaison by 10/1/03

1b. Maintain and Update calendar - ongoing

1c. Existing training catalogued and evaluated - ongoing

1d. Use Washington Learning Management System once established

1e. Identify gaps in training - ongoing

1f. Develop training or curriculum ongoing

1g. Provide training - ongoing

1h. Establish relationships with continuing education coordinators - varies by jurisdiction

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1a. Focus Area B Lead, Focus Area G Coordinator

1b. State Epidemiology Learning Liaison, Regional Learning Specialists, Focus Area B Lead and Regional Epidemiology Coordinators

1c. Epidemiology Learning Liaison, Focus Area G Coordinator, Regional Learning Specialists

1d. Epidemiology Learning Liaison, Focus Area G Coordinator, Regional Learning Specialists and Epidemiology Coordinators

1e. Epidemiology Learning Liaison

1f. Epidemiology Learning Liaison

1g. Epidemiology Learning Liaison, Focus Area G Coordinator, Regional Learning Specialists and Epidemiology Coordinators

1h. Regional Learning Specialists and Epidemiology Coordinators

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

Epidemiology Learning Liaison established and effectively linking focus area B and G

Back to top

  1. Ensure epidemiologic capacity to manage the reportable disease system at the state and local level by providing necessary staffing, supplies, and equipment for epidemiology, surveillance, and interpretation of clinical and laboratory information. (LINK WITH FOCUS AREAS C AND G)

Strategies: What overarching approach(es) will be used to undertake this activity?

1. Maintain State and Regional Surveillance coordinators. Identify regions or local health jurisdictions in need of additional epidemiology support and provide funding for staff or other identified resources. Many regions have elected to develop Communicable Disease Liaison Programs, similar to the one developed in Region 9 to develop a rapport with providers and increase communicable disease reporting. These liaisons provide outreach and information about public health services and programs, disseminate updates about communicable disease treatment and control, work in the field to link providers and their staff with the experts at the LHJ, and perform other tasks necessary to meet the critical capacities.

2. Develop new tools for notifiable condition surveillance and distribute to state, regional and local public health agencies. Tools will include standardized case report forms to improve the quality, completeness and timeliness of notifiable condition surveillance and new technology for electronic disease reporting (i.e., PHIMS, Electronic Laboratory Reporting [ELR], reporting Web site for health care providers)

3. Provide training and education for public health agencies following the development of these products.

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. Work with Regional Lead LHJs to develop 2003-2004 LHJ contract and statement of work for state and regional Epidemiology Surveillance Coordinators.

1b. Identify regions or LHJs in need of additional support.

1c. Develop 2003-2004 LHJ contract and statement of work for regional or local staffing enhancement.

     2a. Complete development of standardized case report forms

2b. Continue to identify, develop and implement appropriate technology solutions to improve notifiable condition surveillance.

3a. Develop training for public health staff on the case report forms and on the Washington State Guidelines for Notifiable Conditions Reporting and Surveillance.

Timeline: What are the critical milestones and completion dates for each task?

1a. LHJ contract including statement of work and deliverables in place by 8/31/03

1b. Regions/LHJs in need of additional support identified by 7/30/03

1c. Contract developed for additional support by 8/30/03

2a. Case report forms redesign initiated by 11/15/03

2b. Participation in User communities – ongoing

3a. Training curriculum written following form revision

3b. Training held in each public health region – varies by region

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1a. Focus Area B Lead and Regional Epidemiology Surveillance Coordinators

1b. Local, regional and state public health agencies

1c. Focus Area B Lead and Regional Epidemiology Surveillance Coordinators

2a. State Surveillance Coordinator; Epidemiology Learning Liaison

2b. State and Regional Surveillance Coordinators

3a. State Surveillance Coordinator, Epidemiology Learning Liaison, Regional Surveillance Coordinators

3b. Epidemiology Learning Liaison, Regional Surveillance Coordinators

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

  • Case report forms developed and distributed
  • Training documented in each public health region

7a. Educate and provide feedback to reporting sources in your jurisdiction about notifiable diseases, conditions, syndromes and their clinical presentations, and reporting requirements and procedures, including those conditions and syndromes that could indicate a terrorist event. (LINK WITH FOCUS AREA G, CROSS CUTTING ACTIVITITY EDUCATION AND TRAINING, Attachment X)

7b. Evaluate training provided to clinicians and other health care providers.

Strategies: What overarching approach(es) will be used to undertake this activity?

1. Regions will employ appropriate strategies such as developing network nurse or public health liaison programs to foster relationships and provide education and training to health care providers and other notifiable conditions reporters. All training will be documented and evaluated by health care providers and notifiable condition reporters. Training materials and information from evaluations will be collected and cataloged to provide a resource for sharing and discussing. Hospitals and clinicians will be provided resources to clarify how they should report to public health agencies. Topics covered will include electronic reporting and Healthcare Insurance Portability and Accountability Act (HIPAA).

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. Continue to develop and update local/regional health care provider networks that will be targeted for outreach, education (including HIPAA) and training.

1b. Use standard materials for face-to-face outreach and training, such as presentations developed in CC #6-10, existing presentations, or new training tools for notifiable condition reporters

1c. Use newsletters, electronic list serves, notes of appreciation and other tools to provide feedback to reporters

1d. Track and manage education and training through link with Focus Area G and the Learning Management System

Timeline: What are the critical milestones and completion dates for each task?

1a. Reporter contact database is updated - ongoing

1b. Training materials developed and shared - ongoing

1c. Enhance communication mechanisms - ongoing

1d. Use Learning Management system when established

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1a. Regional Surveillance Coordinators and/or local communicable disease staff

1b. Regional Surveillance Coordinators and/or local communicable disease staff, Epidemiology Learning Liaison (ELL), Focus Area G Lead and Regional Learning Specialist (RLS)

1c. Regional Surveillance Coordinators and/or local communicable disease staff, ELL, Focus Area G Lead and RLS

1d. ELL, Focus Area G Lead, RLS

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

  • Training documented
  • Catalogue in place
  1. Assess and strengthen links with animal surveillance systems and the animal health community to support early detection efforts of illness among animals.

Strategies: What overarching approach(es) will be used to undertake this activity?

Background: WAC 246-101-405 requires veterinarians to report animal zoonotic diseases to local public health jurisdictions. However, [Information omitted in accordance with R.C.W. 42.17.310(1)(ww)]reports have been received from the veterinary community in the three years since this regulation went into effect. Zoonoses may be underreported due to economic constraints on diagnostic testing and [Information omitted in accordance with R.C.W. 42.17.310(1)(ww)] between the veterinary and public health communities. Currently, Washington has [Information omitted in accordance with R.C.W. 42.17.310(1)(ww)]. Developing such a system will require enhanced collaborations with veterinarians and wildlife agencies.

DOH will initiate an animal disease surveillance system by enhancing communication and establishing laboratory resources for necropsy, diagnostics, and serosurveys. Through surveillance, identify trends in significant zoonotic diseases and formulate control and prevention activities, and establish an early detection program for agents of potential bioterrorism and emerging zoonotic diseases. This will be accomplished though implementation of three strategies:

1. Identify stakeholders/participants in animal disease surveillance

2. Initiate ongoing and regular communication with a steering committee that will perform key tasks.

3. Enhance state, regional and local health collaborations to achieve key tasks

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. Identify stakeholders/participants in animal disease surveillance such as private veterinary practitioners, the state veterinary association, Washington State University College of Veterinary Medicine, Washington State Animal Disease Diagnostic Laboratory (WADDL), the Washington Department of Agriculture, the Washington Department of Fish and Wildlife, wildlife rehabilitators, regional and county health jurisdictions, military bases, humane societies and others that could be integrated into a zoonotic disease surveillance program.

The steering committee will:

2a. Assess the existing infrastructure for animal disease surveillance.

2b. Strengthen key relationships between public health and other agencies involved in animal health.

2c. Develop strategies to initiate an animal disease surveillance program.

2d. In conjunction with Focus Areas C and D, ensure veterinary laboratory capacity to diagnose, detect and monitor diseases in (non-human) animals that are important to human health in Washington.

2e. Develop investigation protocols for zoonotic diseases in animals, beginning with those agents that may have bioterrorism potential.

State, regional and local health agencies will collaborate to:

3a. Establish regular communications on veterinary surveillance.

3b. Facilitate investigations of potential animal disease outbreaks of public health significance including diagnostic support.

3c. Develop collaborative protocols to investigate zoonotic disease cases and outbreaks in animals.

3d. Promote strategies to enhance animal disease diagnostics and case reporting.

Timeline: What are the critical milestones and completion dates for each task?

1a. Initial stakeholders have been identified – completed.

2b. Assessment of current status of veterinary surveillance for zoonotic disease to be completed by December 2003.

3a. List server communication with Regional Epidemiology Coordinators re: veterinary surveillance to be developed by December 2003.

2d. Steering committee to discuss zoonotic disease animal surveillance strategies by December 2003.

3a. DOH and LHJs to disseminate communications about surveillance activities by February 2004.

3c. Develop response protocols for zoonotic disease reports in animals by April 2004.

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1a. State Public Health Veterinarian

2b. State and local Public Health Veterinarians, Epidemiology Response Coordinators, WADDL

3a. State and local Public Health Veterinarians, Epidemiology Response Coordinators, WADDL

2d. State Public Health Veterinarian

3a. State and local Public Health Veterinarians, Epidemiology Response Coordinators

3c. State and local Public Health Veterinarians

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

Protocols for zoonotic disease investigation developed
  1. In coordination with your public health laboratory, develop and implement a strategy to ensure laboratory testing (in clinical or public health laboratories) for rapid or specific confirmation of urgent case reports. (See Appendix 4 for IT Functions #1, 4, and 5.) (LINK WITH FOCUS AREA C)

Strategies: What overarching approach(es) will be used to undertake this activity?

1. In coordination with Focus Area C, (includes DOH Public Health Laboratories [PHL], Spokane Regional Public Health Laboratory and Public Health-Seattle & King County Public Health Laboratories) will assist LHJs and emergency response system partners by providing protocols and training for obtaining rapid testing of suspected bioterrorist agents as appropriate. Protocols will include when specimens (including suspect smallpox) should be referred to PHL or other Laboratory Response Network (LRN) laboratories, the protocol for obtaining testing 24/7, and how to safely package and transport specimens.

2. PHL, as part of pre-event smallpox planning, will identify laboratories in Washington that have the capacity to perform and report LRN-validated testing for variola major, vaccinia and varicella from human and environmental samples. This collaboration will include review of established smallpox emergency procedures and development of specimen collection kits.

     PHL will integrate new, advanced rapid identification methods approved by the LRN into the current testing algorithm for human, environmental, animal, food or water specimens.

3. Link with Focus Area C Critical Benchmark #14 simulation exercise to examine the process for rapid intake, transport, testing and results reporting.

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. Distribute updated suspicious substance/threatening letter sample submission and testing protocol to response system partners on an annual basis

1b. Develop protocols for communication, notification and submission of specimens, including suspect smallpox and incorporate into state, regional and local Epidemiology Response Plans (or overall Public Health Emergency Response Plan as appropriate).

1c. Disseminate and provide training on protocols to appropriate response system partners including health care providers, laboratories and first responders.

1d. Update DOH Notify Website and Washington State Guidelines for Notifiable Conditions Reporting and Surveillance with specimen submission protocols and requirements.

2.a Continue to work closely with PHL to prioritize new testing methods development based on epidemiologic needs as identified.

3.a Work with PHL to include objectives in their required simulation exercise that will examine strengths/weaknesses in current system for submission of samples of suspected bioterrorist agents.

Timeline: What are the critical milestones and completion dates for each task?

1a. Protocol disseminated to LHJs by 10/30/03

1b. Protocols incorporated into state, regional and local plans – varies by jurisdiction

1c. Training provided to response system partners – varies by jurisdiction

1d. Update Guidelines and website with submission protocol initiated by 1/30/04

2a. Meetings with PHL – ongoing

3a. Meetings with PHL – ongoing


 

 

 

 

 

 

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1a. State and Regional Epidemiology Response Coordinators, PHL Training Coordinator

1b. DOH CD Epidemiology, PHL Training Coordinator, and Epidemiology Response Coordinators and RERCs/LERCs

1c. Regional Epidemiology Coordinators

1d. PHL Training Coordinator, State Epidemiology Response Coordinator

2a. DOH CD Epidemiology

3a. State Epidemiology Response Coordinator

 

 

 

 

 

 

 

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

Notify website updated with specimen submission protocols
  1. (Smallpox) Improve the adequacy of state and local public health surveillance and reporting capacities related to smallpox, such as active surveillance for rash illnesses, case contact tracing, and monitoring for adverse events following vaccination.

Back to top

Strategies: What overarching approach(es) will be used to undertake this activity?

1. Revise the surveillance annex of state, regional and local smallpox response plans based on the revised CDC Guide A released in 2003.

2. Develop capacity for rash illness surveillance including report forms and training. Select regions may establish and conduct active surveillance for febrile rash illness using sentinel health care providers (dermatologists, occupational medicine, pediatricians) to determine baseline rates.

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. Revise surveillance annex of state smallpox response plan

1b. Local revisions follow

2a. Revise DOH measles outbreak protocol

2b. Evaluate Stage 1 Smallpox Vaccine Safety Surveillance System including adverse event reporting

Timeline: What are the critical milestones and completion dates for each task?

1a. State smallpox surveillance annex revision initiated by 12/31/03

1b. Local and regional smallpox response plans revised – varies by jurisdiction

2a. Measles outbreak protocol revised by 8/30/04

2b. Stage 1 evaluation completed by 6/30/03

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1a. State and Regional Epidemiology Coordinators, DOH BT Medical Epidemiologist, DOH Immunization Program, Smallpox Program Coordinator

1b. Regional Epidemiology Coordinators

2a. DOH Immunization Program

2b. State and Regional Surveillance Coordinators and Smallpox Program Coordinator

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

Smallpox Surveillance Annex revised
  1. In coordination with local public health agencies, apply information technology according to established specifications, including NEDSS development or the NEDSS Base System, to develop or enhance electronic applications for reportable diseases surveillance, including electronic laboratory-based disease reporting from clinical and public health laboratories and linkage of laboratory results to case report information. (See Appendix 4 for IT Functions #1-5.) (LINK WITH FOCUS AREAS C AND E, CROSS CUTTING ACTIVITITY SURVEILLANCE AND INTEROPERABILITY OF IT SYSTEMS, Attachment X)

Strategies: What overarching approach(es) will be used to undertake this activity?

1. In coordination with Focus Area E, DOH will continue to develop and maintain a secure Web-based system (PHIMS) that LHJs can use to collect notifiable conditions and investigations data, and report it to DOH. DOH will also use this data system for notifiable condition surveillance activities, such as data analysis, quality assurance, and disease reporting to LHJs and the CDC.

A local, regional and state communicable disease and surveillance staff user group will continue regular meetings to discuss policy and other issues that must be addressed prior to system deployment. A subgroup of state and local health officials, the Washington Electronic Disease Surveillance System Steering Committee, will convene monthly to decide on project and policy issues that are beyond the scope of the user group.

DOH’s Office of Communicable Disease Epidemiology will hire an epidemiology data specialist to oversee content review and data coding, incorporating comments and suggestions from the user group and other state and LHJ communicable disease staff.

When Washington Electronic Disease Surveillance System (WEDSS) and Communicable Disease Epidemiology staff determine that PHIMS meets the business requirements and design features documented by the user group and other stakeholders, the system will be piloted, with user acceptance testing, and necessary changes will be documented and incorporated into the system. WEDSS and DOH Communicable Disease Epidemiology will document and assure that necessary infrastructure exists to support PHIMS. When that infrastructure is in place, DOH will deploy PHIMS to state and local public health agencies across Washington State.

In conjunction with the system development, and in collaboration with Focus Area G, training strategies will be identified and audience specific curriculum created. The WEDSS Helpdesk will be enhanced to support PHIMS. Appropriate state and regional epidemiology coordinators and local communicable disease staff will be trained to provide technical support for the system.

2. Laboratories will continue to build technology infrastructure consistent with electronic data standards to support electronic data interchange with public health partners. DOH will continue to guide these efforts by providing standards built on the Public Health Information Network (PHIN) and other national standards. As laboratories develop the capacity to meet the IT standards through modification of existing information systems or creation of new systems, DOH will provide implementation guidelines for laboratories to send electronic messages. Additionally, DOH will build systems for sharing information by modifying software code from other states or sources. This electronic messaging system will be pilot tested prior to implementation in laboratories across the state. The end-product will be able to accept notifiable conditions reports from clinical and hospital laboratories and deliver reports to appropriate LHJs using PHIN standards including required coding formats.

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. Continue PHIMS user group meetings

1b. Hire DOH Communicable Disease Epidemiology data specialist

1c. Standardize and build consensus on PHIMS content, including data elements and coding

1d. Review PHIMS application against business requirements and functional needs; accept for deployment if appropriate

1e. Test and deploy application to select pilot jurisdictions; implement changes based on results

1f. Develop and provide training to local, regional and state PHIMS users

1g. Document and assure infrastructure to support PHIMS is in place at DOH

1h. Deploy PHIMS to state and local public health agencies

2a. Provide implementation guidelines for electronic messaging to hospital and clinical laboratories

2b. Build electronic messaging system to collect notifiable condition reports from laboratories and deliver same to appropriate state and local public health agencies

2c. Pilot-test electronic messaging system

2d. Deploy system to prioritized labs

Timeline: What are the critical milestones and completion dates for each task?

1a. PHIMS user group meetings held on a monthly basis

1b. DOH Communicable Disease Epidemiology data specialist hired by 9/1/03

1c. PHIMS content standardized and accepted by system stakeholders by 9/1/03

1d. Review of PHIMS application against business requirements and functional needs initiated by 9/15/03

1e. PHIMS deployed to select LHJs for pilot testing by 12/01/03

1f. PHIMS training curriculum and training plan developed by 11/15/03

1g. Infrastructure needs for PHIMS support documented and addressed by 9/30/03

1h. PHIMS deployed to state and local public health agencies beginning 1/1/04

2a. Implementation guidelines for electronic messaging from hospital and clinical laboratories provided by 10/1/2003

2b. Electronic messaging system to collect notifiable condition reports from laboratories and deliver same to appropriate state and local public health agencies built by 11/1/2003

2c. Pilot-test electronic messaging system initiated by 11/1/2003

2d. System deployed to prioritized labs by 1/1/2004

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1a. WEDSS, State and Regional Surveillance Coordinators, local communicable disease staff

1b. DOH Communicable Disease Epidemiology

1c. DOH Communicable Disease Epidemiology, WEDSS, PHIMS user group, local communicable disease staff

1d. WEDSS, DOH Communicable Disease Epidemiology

1e. WEDSS, select local health jurisdictions

1f. WEDSS, State Epidemiology Learning Liaison, Focus Area G

1g. WEDSS, DOH Communicable Disease Epidemiology

1h. WEDSS, state and local public health agencies

2a. WEDSS

2b. WEDSS

2c. WEDSS, select laboratories

2d. WEDSS, laboratories

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

  • Percentage of LHJs with access to PHIMS
  1. In coordination with your public health laboratory, develop the capacity to apply molecular epidemiologic methods (e.g., pulsed field gel electrophoresis or sequence-based methods) to outbreak investigations and surveillance as appropriate. (LINK WITH FOCUS AREA C)

Back to top

Strategies: What overarching approach(es) will be used to undertake this activity?

1. Collaborate with the Washington State Public Health Laboratories (PHL) microbiology molecular laboratory to ensure the best mechanism is used for molecular testing and for sharing testing results with epidemiologists at DOH and LHJs. This will enhance their ability to identify clusters and outbreaks.

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. Work with PHL molecular laboratory to determine information needed to enhance DOH and LHJs’ ability to identifying clusters and outbreaks

1b. PHL molecular laboratory will develop a nomenclature for enteric subtypes which will help epidemiologists gain expertise in understanding implications of certain patterns and historical trends

1c. Add molecular subtyping results to daily enteric report provided by the PHL

1d. Work with PHL to expand scope of organisms for which routine subtyping is performed, as appropriate

Timeline: What are the critical milestones and completion dates for each task?

1a. Meet routinely with PHL ongoing

1b. Nomenclature developed 11/1/03

1c. Subtype results added to daily report by 11/15/03

1d. Work to expand list of organisms for routine subtyping – ongoing

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1a. DOH Communicable Disease Epidemiology and PHL pulsed-filed gel electrophoresis (PFGE) Laboratory

1b. PHL PFGE Microbiologist

1c. PHL PFGE Lab and DOH Communicable Disease Epidemiology

1d. PHL PFGE Lab and DOH Communicable Disease Epidemiology

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

  • PFGE type added to daily report
  • Library of enteric subtypes created

Back to top

  1. Integrate infectious disease surveillance by establishing relationship with state veterinary diagnostic laboratory. Evaluate database system for identification and tracking of zoonotic diseases. Conduct survey of veterinary practitioners regarding laboratory utilization and specimen submission practices.

Strategies: What overarching approach(es) will be used to undertake this activity?

1. Develop and enhance collaborations between state and local public health departments, and the Washington Animal Disease Diagnostic Laboratory (WADDL). Develop protocols for local health to respond to and track zoonotic diseases in animals and humans. Evaluate the use of veterinary laboratories by the veterinary and animal health community in order to determine priorities for enhancing the relationships and animal disease surveillance strategies.

Tasks: What key tasks will be conducted in carrying out each identified strategy?

1a. In conjunction with Focus area C, identify capacities and needs to develop enhanced zoonotic disease testing at WADDL and PHL.

1b. Conduct survey of veterinarians regarding laboratory utilization and submission practices.

Timeline: What are the critical milestones and completion dates for each task?

1a. DOH and WADDL to identify existing capacities and explore potential needs for enhanced zoonotic disease surveillance in animals by February 2004.

1b. Survey of veterinarians initiated by April 2004

1c. Notification to stakeholders of available laboratory capacity for animal disease surveillance to be done by December 2003.

Responsible Parties: Identify the person(s) and/or entity assigned to complete each task.

1a. WADDL, PHL, State and local Public Health Veterinarians, Regional Epidemiology Coordinators

1b. WADDL, PHL, State Public Heath Veterinarian, Region 6 Public Health Veterinarian, Regional Epidemiology Coordinators

1c. WADDL, PHL, State Public Heath Veterinarian

Evaluation Metric: How will the agency determine progress toward successful completion of the overall recipient activity?

Survey of veterinarians completed

Back to